Home » Topics » BioWorld Science

BioWorld Science
RSS

Researchers unveil ACOT13, PTGER2 as candidate genes of autosomal dominant polycystic kidney disease

Dec. 21, 2021

New ATR kinase inhibitors discovered at Shenzhen Life Fountain Biotech

Dec. 21, 2021

Hongyun Biotech identifies new EGFR inhibitors

Dec. 21, 2021

Celularity and Sorrento Therapeutics present preclinical data for CAR19-CYNK immunotherapeutic

Dec. 20, 2021

Discovery of T-036, a novel brain-penetrant GCS inhibitor for the treatment of Gaucher's disease

Dec. 20, 2021

SRSF1 is a therapeutic target for the treatment of breast cancer

Dec. 20, 2021

DAN-311 demonstrates consistent and durable efficacy in HER2-low breast cancer models

Dec. 20, 2021

PFKFB3 targeting shows promise for treating breast cancer

Dec. 20, 2021

Researchers discover more than 1,300 genes linked to congenital heart disease

Dec. 20, 2021

Novel CD70-directed CAR-NK cells for the treatment of CD70-positive malignancies

Dec. 20, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...